Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome
Abstract The incidence of metabolic syndrome is significantly higher in patients with irritable bowel syndrome (IBS), but the mechanisms involved remain unclear. Gut microbiota is causatively linked with the development of both metabolic dysfunctions and gastrointestinal disorders, thus gut dysbiosi...
Main Authors: | Lixiang Zhai, Haitao Xiao, Chengyuan Lin, Hoi Leong Xavier Wong, Yan Y. Lam, Mengxue Gong, Guojun Wu, Ziwan Ning, Chunhua Huang, Yijing Zhang, Chao Yang, Jingyuan Luo, Lu Zhang, Ling Zhao, Chenhong Zhang, Johnson Yiu-Nam Lau, Aiping Lu, Lok-Ting Lau, Wei Jia, Liping Zhao, Zhao-Xiang Bian |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-40552-y |
Similar Items
-
Mechanism of Action of Kynurenic Acid in Irritable Bowel Syndrome
by: LU Jinnan, et al.
Published: (2023-03-01) -
2-Phenethylamines in Medicinal Chemistry: A Review
by: Carlos T. Nieto, et al.
Published: (2023-01-01) -
Novel Psychoactive Phenethylamines: Impact on Genetic Material
by: Veronica Cocchi, et al.
Published: (2020-12-01) -
Unusual phenethylamine-containing alkaloids from Elaeocarpus tectorius
by: Ezeoke, Margret Chinonso, et al.
Published: (2018) -
In vitro neuro- and hepatotoxic profile of new psychoactive phenethylamines
by: Eva Gil-Martins, et al.
Published: (2022-04-01)